Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Accured Expenses (2019 - 2026)

Nutex Health (NUTX) has disclosed Change in Accured Expenses for 8 consecutive years, with $5.2 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 777.5% year-over-year to $5.2 million; the TTM value through Mar 2026 reached $7.6 million, up 9.09%, while the annual FY2025 figure was $1.6 million, 87.15% down from the prior year.
  • Change in Accured Expenses hit $5.2 million in Q1 2026 for Nutex Health, up from -$923000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $9.4 million in Q2 2022 and bottomed at -$6.9 million in Q3 2022.
  • Average Change in Accured Expenses over 5 years is $1.4 million, with a median of $1.9 million recorded in 2023.
  • Year-over-year, Change in Accured Expenses tumbled 703.66% in 2022 and then skyrocketed 1269.8% in 2023.
  • Nutex Health's Change in Accured Expenses stood at -$4.0 million in 2022, then skyrocketed by 58.42% to -$1.7 million in 2023, then tumbled by 152.2% to -$4.2 million in 2024, then surged by 78.13% to -$923000.0 in 2025, then soared by 664.46% to $5.2 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $5.2 million, -$923000.0, and $347000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.